A Comparative Study of Chest Computed Tomography Findings: 1030 Cases of Drug-Sensitive Tuberculosis versus 516 Cases of Drug-Resistant Tuberculosis

References

• World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.
   Google Scholar
• Pontali E, Raviglione MC, Migliori GB, et al. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. Eur Respir Rev. 2019;28(152):190035. doi:10.1183/16000617.0035-201931142549
   PubMed Web of Science ®Google Scholar
• Lange C, Dheda K, Chesov D, et al. Management of drug-resistant tuberculosis. Lancet. 2019;394(10202):953–966. doi:10.1016/S0140-6736(19)31882-331526739
   PubMed Web of Science ®Google Scholar
• Rasool G, Khan AM, Mohy-Ud-Din R, et al. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert® MTB/RIF assay. Int J Immunopathol Pharmacol. 2019;33:1–6. doi:10.1177/2058738419827174
   Web of Science ®Google Scholar
• Suárez I, Fünger SM, Kröger S, et al. The diagnosis and treatment of tuberculosis. Dtsch Arztebl Int. 2019;116(43):729–735. doi:10.3238/arztebl.2019.072931755407
   PubMed Web of Science ®Google Scholar
• Hansell DM, Bankier AA, MacMahon H, et al. Fleischner society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722. doi:10.1148/radiol.246207071218195376
   PubMed Web of Science ®Google Scholar
• Zürcher K, Ballif M, Fenner L, et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis. 2019;19(3):298–307. doi:10.1016/S1473-3099(18)30673-X30744962
   PubMed Web of Science ®Google Scholar
• Nguyen QH, Contamin L, Nguyen TVA, et al. Insights into the processes that drive the evolution of drug resistance in Mycobacterium tuberculosis. Evol Appl. 2018;11(9):1498–1511. doi:10.1111/eva.1265430344622
   PubMed Web of Science ®Google Scholar
• Elduma AH, Mansournia MA, Foroushani AR, et al. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study. Epidemiol Health. 2019;41:e2019014. doi:10.4178/epih.e201901431010280
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu J. Significance of the differential peptidome in multidrug-resistant tuberculosis. Biomed Res Int. 2019;2019:5653424.30792993
   PubMed Web of Science ®Google Scholar
• Lee EH, Yong SH, Leem AY, et al. Improved fluoroquinolone-resistant and extensively drug-resistant tuberculosis treatment outcomes. Open Forum Infect Dis. 2019;6(4):ofz118. doi:10.1093/ofid/ofz11830949546
   PubMed Web of Science ®Google Scholar
• Basit A, Ahmad N, Khan AH, et al. Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study. PLoS One. 2014;9(4):e93206. doi:10.1371/journal.pone.009320624705411
   PubMed Web of Science ®Google Scholar
• Huang Q, Yin Y, Kuai S, et al. The value of initial cavitation to predict re-treatment with pulmonary tuberculosis. Eur J Med Res. 2016;21(1):20. doi:10.1186/s40001-016-0214-027154410
   PubMed Web of Science ®Google Scholar
• Chuchottaworn C, Thanachartwet V, Sangsayunh P, et al. Risk factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis at the central chest institute of Thailand. PLoS One. 2015;10(10):e0139986. doi:10.1371/journal.pone.013998626444421
   PubMed Web of Science ®Google Scholar
• Wong KS, Huang YC, Lai SH, et al. Validity of symptoms and radiographic features in predicting positive AFB smears in adolescents with tuberculosis. Int J Tuberc Lung Dis. 2010;14(2):155–159.20074405
   PubMed Web of Science ®Google Scholar
• Ihms EA, Urbanowski ME, Bishai WR. Diverse cavity types and evidence that mechanical action on the necrotic granuloma drives tuberculous cavitation. Am J Pathol. 2018;188(7):1666–1675. doi:10.1016/j.ajpath.2018.04.00629753789
   PubMed Web of Science ®Google Scholar
• Wáng YXJ, Chung MJ, Skrahin A, Rosenthal A, Gabrielian A, Tartakovsky M. Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences. Quant Imaging Med Surg. 2018;8(2):161–173. doi:10.21037/qims.2018.03.0629675357
   PubMed Web of Science ®Google Scholar
• Li D, He W, Chen B, et al. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: comparisons of CT findings. PLoS One. 2017;12(6):e0176354. doi:10.1371/journal.pone.017635428586348
   PubMed Web of Science ®Google Scholar
• Metcalfe JZ, Makumbirofa S, Makamure B, et al. Drug-resistant tuberculosis in high-risk groups, Zimbabwe. Emerg Infect Dis. 2014;20(1):135–137. doi:10.3201/eid2001.13073224377879
   PubMed Web of Science ®Google Scholar
• Walker NF, Stek C, Wasserman S, et al. The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research. Curr Opin HIV AIDS. 2018;13(6):512–521. doi:10.1097/COH.000000000000050230124473
   PubMed Web of Science ®Google Scholar
• Ordonez AA, Tasneen R, Pokkali S, et al. Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9. Dis Model Mech. 2016;9(7):779–788. doi:10.1242/dmm.02564327482816
   PubMed Web of Science ®Google Scholar
• Cheon H. Comparison of CT findings of between MDR-TB and XDR-TB: a propensity score matching study. Imaging Med. 2017;9:125–129.
   Google Scholar
• Shin SS, Keshavjee S, Gelmanova IY, et al. Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment. Am J Respir Crit Care Med. 2010;182(3):426–432. doi:10.1164/rccm.200911-1768OC20413630
   PubMed Web of Science ®Google Scholar
• Jeong YJ, Lee KS. Pulmonary tuberculosis: up-to-date imaging and management. AJR Am J Roentgenol. 2008;191(3):834–844. doi:10.2214/AJR.07.389618716117
   PubMed Web of Science ®Google Scholar
• Woodman M, Haeusler IL, Grandjean L. Tuberculosis genetic epidemiology: a Latin American perspective. Genes (Basel). 2019;10(1):53. doi:10.3390/genes10010053
   Web of Science ®Google Scholar
• Chandrasekaran R, Mac AM, Chalmers JD, et al. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med. 2018;18(1):83. doi:10.1186/s12890-018-0638-029788932
   PubMed Web of Science ®Google Scholar
• Schäfer J, Griese M, Chandrasekaran R, et al. Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis. BMC Pulm Med. 2018;18(1):79. doi:10.1186/s12890-018-0630-829788954
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Gupta A, Janmeja AK, et al. Evaluation of tuberculosis-associated chronic obstructive pulmonary disease at a tertiary care hospital: a case-control study. Lung India. 2017;34(5):415–419. doi:10.4103/lungindia.lungindia_522_1628869224
   PubMedGoogle Scholar
• Pettigrew MM, Tsuji BT, Gent JF, et al. Effect of fluoroquinolones and macrolides on eradication and resistance of Haemophilus influenzae in chronic obstructive pulmonary disease. Antimicrob Agents Chemother. 2016;60(7):4151–4158. doi:10.1128/AAC.00301-1627139476
   PubMed Web of Science ®Google Scholar
• Ben Saad-Baouab S, Hantous S, Daghfous H, et al. Contribution of imaging in the management of resistant tuberculosis. Tunis Med. 2019;97(3):445–454.31729719
   PubMedGoogle Scholar
• Song Q, Zhang G, Jiang H, et al. Imaging features of pulmonary CT in type 2 diabetic patients with multidrug-resistant tuberculosis. PLoS One. 2016;11(3):e0152507. doi:10.1371/journal.pone.015250727022735
   PubMed Web of Science ®Google Scholar
• Nahid P, Mase SR, Migliori GB, et al. Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200(10):e93–e142. doi:10.1164/rccm.201909-1874ST31729908
   PubMed Web of Science ®Google Scholar